Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer

To the Editor In the March issue of JAMA Oncology, Melisko and colleagues published their randomized trial. We are concerned that their registration was delayed and their article is an example of selective outcome reporting.

http://ift.tt/2tj8CVP